---
title: "Fermenta Biotech Ltd (506414) — Share Price, Financials & Analysis"
symbol: "506414"
company: "Fermenta Biotech Ltd"
canonical: "https://tapetide.com/stocks/506414"
isin: "INE225B01021"
nse_symbol: "FERMENTA"
bse_code: "506414"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 1393.41
generated_at: "2026-09-13T19:31:31.315Z"
---

# Fermenta Biotech Ltd (506414)

Canonical page: https://tapetide.com/stocks/506414

## Company

- **NSE Symbol:** FERMENTA
- **BSE Code:** 506414
- **ISIN:** INE225B01021
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2026-08-04
- **CEO:** Mr. Prashant Prabhakar Nagre
- **Employees:** 606
- **Face Value:** ₹5
- **F&O Eligible:** No
- **Website:** dil.net

## About

Incorporated in 1951, Fermenta Biotech 
Ltd manufactures Active Pharmaceutical Ingredient, Aqua CHL, Biotechnology and Nutraceutical products[1]

## Latest Price

- **Price:** ₹474.65
- **Change:** -9 (-1.86%)
- **Open:** ₹484
- **Day High:** ₹484
- **Day Low:** ₹471
- **Previous Close:** ₹483.65
- **Volume:** 53319
- **As Of:** 2026-09-11T10:01:40+00:00

## Key Fundamentals

Observed at 2026-09-11T04:44:14.984736Z.

- **Market Cap:** ₹1393.41 Cr
- **Classification:** Microcap
- **P/E (reported):** 24.5
- **P/E (TTM):** 23.4
- **EPS (TTM):** ₹20.28
- **Book Value:** ₹138.15
- **Price to Book:** 3.5
- **Dividend Yield:** 0.78%
- **ROE:** 17.54%
- **ROCE:** 24.46%
- **Debt to Equity:** 0.28
- **Revenue (yearly):** ₹547.8 Cr
- **Net Income:** ₹70.3 Cr
- **EBITDA:** ₹122.2 Cr
- **52-Week High:** ₹580.45
- **52-Week Low:** ₹248.85
- **RSI (14):** 50.55

## Tapetide Score

- **Score:** 60 / 100
- **Score date:** 2026-09-04
- **Archetype:** Average Quality, Undemanding Price
- **What it means:** The financials sit mid-range rather than strong, and the multiple is not demanding. Nothing here stands out in either direction, so the read comes down to which single pillar you weight most and whether the next results move it off the middle.
- **Pillar profile:** Quality: Average · Valuation: Cheap · Momentum: Rising
- **Percentile:** 87.9 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 53.35 | 9% |
| growth | 7.89 | 9% |
| momentum | 83.4 | 12% |
| ownership | 61.46 | 24% |
| quality | 54.77 | 22% |
| valuation | 76.48 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- The company has delivered a poor sales growth of 6.85% over past five years.
- Company has a low return on equity of 12.6% over last 3 years.
- Working capital days have increased from 48.7 days to 96.2 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 126.97% | -11.88% | 113.7% |
| ebitda margin growth | -34.31% | -11.71% | 97.08% | 30.39% |
| net income growth | -48.92% | -7.98% | 65% | 7% |
| revenue growth | -7% | 13.82% | 14% | 7% |
| roce | -40.65% | 1.12% | — | 10.45% |
| roe | -48.76% | -17.69% | 10.14% | 333.09% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 56.91 | 98.97 | 97.34 | 78.13 | 95.03 | 156.47 | 139.85 | 136.26 | 130.22 | 137.36 | 121.58 | 121.82 |
| Expenses | 70.82 | 73.84 | 91.96 | 77.33 | 76.25 | 103.2 | 102.9 | 108.02 | 103.58 | 112.4 | 101.58 | 103.76 |
| Operating Profit | -13.91 | 25.13 | 5.38 | 0.8 | 18.78 | 53.27 | 36.95 | 28.24 | 26.64 | 24.96 | 20 | 18.06 |
| OPM % | -24.44 | 25.39 | 5.53 | 1.02 | 19.76 | 34.04 | 26.42 | 20.73 | 20.46 | 18.17 | 16.45 | 14.83 |
| Other Income | -5.53 | 2.52 | 5.38 | 2.82 | 2.88 | 2.23 | 3.89 | 8.77 | 5.43 | 0.92 | 14.14 | 4.37 |
| Interest | 3.69 | 5.19 | 3.39 | 3.43 | 3.69 | 4.08 | 2.99 | 3.11 | 2.58 | 3.03 | 2.82 | 2.54 |
| Depreciation | 5.93 | 6.38 | 6.46 | 6.12 | 6.15 | 6.08 | 5.86 | 5.81 | 5.41 | 5.37 | 5.11 | 5.2 |
| Profit before tax | -29.06 | 16.08 | 0.91 | -5.93 | 11.82 | 45.34 | 31.99 | 28.09 | 24.08 | 17.48 | 26.21 | 14.69 |
| Tax % | 0 | 37.81 | 884.62 | 0 | 5.92 | 16.43 | -4.19 | 23.07 | 25.17 | 31.24 | 29.03 | 35.13 |
| Net Profit | -29.07 | 9.99 | -7.14 | -5.93 | 11.12 | 37.89 | 33.32 | 21.6 | 18.03 | 12.02 | 18.6 | 9.53 |
| EPS in Rs | -9.7 | 3.35 | -2.36 | -1.98 | 3.87 | 12.54 | 11.68 | 7.42 | 6.14 | 4.31 | 6.52 | 3.31 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 302 | 403 | 292 | 376 | 397 | 349 | 335 | 468 | 523 | 511 |
| Expenses | 209 | 248 | 225 | 293 | 335 | 330 | 307 | 352 | 422 | 421 |
| Operating Profit | 93 | 156 | 66 | 83 | 62 | 18 | 28 | 115 | 101 | 90 |
| OPM % | 31 | 39 | 23 | 22 | 16 | 5 | 8 | 25 | 19 | 18 |
| Other Income | 9 | 6 | 12 | 8 | 8 | -20 | 4 | 7 | 29 | 25 |
| Interest | 14 | 21 | 20 | 19 | 18 | 21 | 17 | 15 | 13 | 11 |
| Depreciation | 12 | 12 | 15 | 20 | 26 | 28 | 25 | 24 | 22 | 21 |
| Profit before tax | 76 | 129 | 43 | 52 | 27 | -51 | -10 | 83 | 96 | 82 |
| Tax % | 28 | 8 | -37 | 18 | 44 | 4 | 143 | 8 | 27 | — |
| Net Profit | 46 | 117 | 60 | 43 | 15 | -53 | -24 | 76 | 70 | 58 |
| EPS in Rs | 12.21 | 42.71 | 20.23 | 15.46 | 5.25 | -17.36 | -7.84 | 26.12 | 24.39 | 20.28 |
| Dividend Payout % | 2 | 1 | 24 | 16 | 23 | -7 | -16 | 9 | 15 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 2 | 2 | 5 | 14 | 14 | 14 | 14 | 14 | 15 | 14 |
| Reserves | 142 | 122 | 246 | 295 | 346 | 358 | 301 | 274 | 348 | 392 |
| Borrowings | 87 | 173 | 209 | 224 | 232 | 239 | 220 | 139 | 115 | 113 |
| Other Liabilities | 75 | 87 | 92 | 80 | 94 | 96 | 102 | 120 | 137 | 128 |
| Total Liabilities | 307 | 385 | 551 | 614 | 687 | 707 | 637 | 548 | 614 | 648 |
| Fixed Assets | 172 | 177 | 178 | 200 | 263 | 299 | 267 | 269 | 227 | 220 |
| CWIP | 5 | 4 | 22 | 71 | 57 | 35 | 45 | 2 | 16 | 13 |
| Investments | 18 | 10 | 8 | 0 | 0 | 0 | 3 | 0 | 0 | 0 |
| Other Assets | 112 | 193 | 344 | 342 | 367 | 373 | 321 | 277 | 372 | 414 |
| Total Assets | 307 | 385 | 551 | 614 | 687 | 707 | 637 | 548 | 614 | 648 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 2 | 59 | 90 | 34 | 63 | 43 | 116 | 105 | 41 | 93 |
| Cash from Investing Activity | 7 | -101 | -97 | -44 | -41 | -26 | -55 | -16 | 0 | -43 |
| Cash from Financing Activity | -12 | 89 | 12 | -47 | -1 | -22 | -41 | -91 | -51 | -42 |
| Net Cash Flow | -4 | 47 | 6 | -57 | 21 | -4 | 19 | -1 | -10 | 8 |
| Free Cash Flow | -17 | 42 | 55 | -34 | 7 | 6 | 76 | 86 | 38 | 63 |
| CFO/OP | 35 | 83 | 79 | 73 | 92 | 85 | 610 | 370 | 38 | 108 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 99 | 83 | 59 | 87 | 66 | 80 | 44 | 76 | 74 | 78 |
| Inventory Days | 208 | 234 | 347 | 594 | 441 | 380 | 309 | 245 | 285 | 290 |
| Days Payable | 147 | 183 | 169 | 260 | 169 | 154 | 109 | 182 | 178 | 147 |
| Cash Conversion Cycle | 160 | 134 | 237 | 421 | 338 | 306 | 244 | 139 | 181 | 221 |
| Working Capital Days | 33 | 54 | 43 | 70 | 54 | 67 | -18 | 9 | 40 | 96 |
| ROCE % | 2 | 31 | 41 | 12 | 13 | 7 | 0 | 3 | 23 | 21 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 62.06% | 62.06% | 62.06% | 62.06% | 62.06% | 62.06% | 64.09% | 64.09% | 64.09% | 64.09% | 64.09% | 64.09% |
| FIIs | 0% | 0% | 0% | 0% | 0.05% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.13% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.04% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 32.37% | 32.56% | 32.47% | 32.51% | 31.29% | 32.31% | 30.38% | 29.6% | 29.76% | 29.48% | 28.8% | 28.33% |
| Others | 5.57% | 5.38% | 5.47% | 5.43% | 6.59% | 5.6% | 5.51% | 6.29% | 6.12% | 6.41% | 7.09% | 7.42% |
| No. of Shareholders | 15721 | 15150 | 15178 | 14589 | 13221 | 12922 | 12930 | 12845 | 13760 | 14139 | 13661 | 14131 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 8 / 6 / 5

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 493.73 | Sell |
| EMA (10) | 487.89 | Sell |
| SMA (20) | 482.51 | Sell |
| EMA (20) | 485.73 | Sell |
| SMA (50) | 468.44 | Buy |
| EMA (50) | 459.47 | Buy |
| SMA (100) | 393.11 | Buy |
| EMA (100) | 419.45 | Buy |
| SMA (200) | 359.04 | Buy |
| EMA (200) | 380.24 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 48 | Neutral |
| MACD (12,26,9) | 5.93 | Sell |
| Stochastic (14,3,3) | 34.5 | Neutral |
| ADX (14) | 16.94 | Neutral |
| Williams %R (14) | -77.23 | Neutral |
| ATR (14) | 26.47 | High Volatility |
| ROC (12) | 1.53 | Buy |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 37.17 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Press Release Regarding Exclusive Licence Agreement With Vellore Institute Of Technology (VIT) Vellore For Vitamin B12 Fortification Technology.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41e8e62b-6655-4a38-b120-4e5eccd4bb9a.pdf) |
| 2026-08-27 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc699cb0-c8b6-4ddb-86ec-bc153d5a8f0c.pdf) |
| 2026-08-26 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65fefdb1-7390-4332-9e6b-49f437308c72.pdf) |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Credit Rating](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f3f9801-d053-4ce8-9f0a-463373c3b51e.pdf) |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe8c7bc9-42fd-4e86-b7af-e013b15a1f32.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1ccc8ff-5ada-41a6-99d6-3130d0e2b101.pdf) |
| 2026-08-11 | [Board Meeting Outcome for Outcome Of Board Meeting And Unaudited Financial Results - June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f739ae56-dd07-4e7a-9327-48bdebdfae8e.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dd62b61-a29d-4143-8128-953caa4cf430.pdf) |
| 2026-08-11 | [Presentation For Shareholders At 74Th Annual General Meeting (AGM)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dde7f112-2b96-485a-b7bf-efca23f25dac.pdf) |
| 2026-08-11 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09be3d3c-6b35-4bbc-8269-0925043a3954.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-11 | [Unaudited Financial Results For Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1e0e8b3-fd46-46ab-a06d-023b72fc5f83.pdf) |
| 2026-05-26 | [Audited Financial Statements (Standalone And Consolidated) For Quarter & Year Ended March 31 2026 Along With Auditors Report Thereon Along With Information For AGM And Dividend](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33510cbf-f3f3-478f-afcf-27a974352226.pdf) |
| 2026-02-09 | [Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed0cb745-9890-4673-afe4-ce96e551891f.pdf) |
| 2025-11-11 | [Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21fd9e68-5f08-4fba-884c-7b4c275ca4be.pdf) |
| 2025-08-12 | [Unaudited Financial Results For Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b1b24f3-76b0-4c29-b5ad-9aa9f6dd9824.pdf) |
| 2025-05-28 | [Results - Financial Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65136a3f-fac3-46f6-b325-d6e1dd27e1c1.pdf) |
| 2025-02-11 | [Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ffa62989-39ec-4fb4-b16f-a6fbb604c7d8.pdf) |
| 2024-11-14 | [Unaudited Financial Results For Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cd563de-5b94-475a-b076-ac5fccbdd252.pdf) |
| 2024-08-12 | [Unaudited Financial Results For June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=928a886d-cc22-49da-9669-fa3dcd953796.pdf) |
| 2024-05-27 | [Results - Financial Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd2aab8a-b0b5-4ae9-ac35-41c46c8a4d04.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28e5c80e-41d4-4984-acf8-6f0165783e45.pdf) |
| 2026-05-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7171e1b4-477b-4bd8-a5ef-ad4746085831.pdf) |
| 2025-11-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=157d97c1-5f2f-4070-aca2-380cc8e86b97.pdf) |
| 2025-08-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea0b7a9d-cf96-461f-8c8f-79adb5111d7f.pdf) |
| 2025-06-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce632a00-5216-4272-abba-fa68baa5717c.pdf) |
| 2025-02-18 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90f3346d-fb42-42a9-b52a-522bf42e79f4.pdf) |
| 2024-11-18 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08da464c-d3c9-4558-b54c-011c5a7d7343.pdf) |
| 2024-07-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d063fc4f-274f-40f1-8506-30e3a0a201d5.pdf) |
| 2024-06-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d7f8096-42cc-44ca-9ac1-1407261693d5.pdf) |
| 2024-06-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abf721fb-cad6-4581-98c3-13543b185d0f.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Board approved unaudited standalone and consolidated results for quarter and nine months ended Dec 31, 2025; LR Feb 9, 2026. | [Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025 9 Feb - Board approved unaudited standalone and consolidated results for quarter and nine months ended Dec 31, 2025; LR Feb 9, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ccbf17ea-b14a-48e4-a707-edfad812c2eb.pdf) |
| 9 Feb - 9MFY26 consolidated revenue INR 413.6 crore; PAT INR 51.7 crore; INR 110 crore Dahej capex approved. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 9 Feb - 9MFY26 consolidated revenue INR 413.6 crore; PAT INR 51.7 crore; INR 110 crore Dahej capex approved.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0a36c907-2416-44b8-b95d-b07082cbc166.pdf) |
| 7 May - Publication of IEPF related notice for equity shareholders | [Announcement under Regulation 30 (LODR)-Newspaper Publication 7 May - Publication of IEPF related notice for equity shareholders](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b510ef47-9fb2-43a7-9b1e-266ab9af8fc7.pdf) |
| 31 Mar - Trading window closed Apr 1, 2026 until 48 hours after results for quarter/FY ending March 31, 2026. | [Closure of Trading Window 31 Mar - Trading window closed Apr 1, 2026 until 48 hours after results for quarter/FY ending March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/90fa098b-20f5-4a2b-8c93-0b34d53cdf65.pdf) |
| 30 Oct 2025 - Newspaper Advertisement of Unaudited Standalone and Consolidated Financial Results for the Half Year Ended 30th September 2025. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 30 Oct 2025 - Newspaper Advertisement of Unaudited Standalone and Consolidated Financial Results for the Half Year Ended 30th September 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/945db85f-9a2f-46da-8c98-b50a0a66149a.pdf) |
| 29 Oct 2025 - Mayank Cattle Food updates KMP contacts after Company Secretary cessation; contacts listed Oct 29, 2025. | [Disclosure Under Regulation 30(5) Of The SEBI (LODR) Regulations, 2015. 29 Oct 2025 - Mayank Cattle Food updates KMP contacts after Company Secretary cessation; contacts listed Oct 29, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3ec2204d-ff50-4475-963b-2eac68602fb6.pdf) |
| 29 Oct 2025 - H1 ending Sep 30, 2025: Standalone revenue Rs1,853.86m; PAT Rs25.24m; EPS Rs4.67. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 29 Oct 2025 - H1 ending Sep 30, 2025: Standalone revenue Rs1,853.86m; PAT Rs25.24m; EPS Rs4.67.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f51a12fd-49a9-4245-861c-d9065e68eaef.pdf) |
| 28 Feb - Publication of notice for Special window for transfer and dematerialisation of physical securities | [Announcement under Regulation 30 (LODR)-Newspaper Publication 28 Feb - Publication of notice for Special window for transfer and dematerialisation of physical securities](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7c652cc0-1df0-4227-805a-109c23386d3d.pdf) |
| 28 Apr - Newspaper Publication for Notice for Special window for Transfer and Dematerialisation of Physical Securities. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 28 Apr - Newspaper Publication for Notice for Special window for Transfer and Dematerialisation of Physical Securities.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e3a8b605-8124-41e2-8a53-8066cf74ecb4.pdf) |
| 28 Apr - Newspaper Publication for Notice for Special window for Transfer and Dematerialisation of Physical Securities. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 28 Apr - Newspaper Publication for Notice for Special window for Transfer and Dematerialisation of Physical Securities.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/e3a8b605-8124-41e2-8a53-8066cf74ecb4.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2023 | [Concall - Sep 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c750e2f3-5d04-491a-ad1a-e031a01df864.pdf) |
| Sep 2022 | [Concall - Sep 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/77a66732-f9c6-4468-9339-7fbae2e7aadf.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/157d97c1-5f2f-4070-aca2-380cc8e86b97.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/08da464c-d3c9-4558-b54c-011c5a7d7343.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72d9cddd-b33d-461f-a3e0-3896b186ca37.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c157af7-9026-4d51-8893-d16efb14b2a2.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/72d9cddd-b33d-461f-a3e0-3896b186ca37.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1c157af7-9026-4d51-8893-d16efb14b2a2.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8222102c-36fc-4a94-a250-672d836b4be6.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e96f9d5-0248-4a25-bd39-48e5a5ab55de.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a904abaa-a8f2-49f3-839a-9a552595f506.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e3643fee-7975-4576-8625-8c72f8aa907d.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3010155e-4b55-42a2-a549-ba9b53873915.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/69abba8c-59da-4aaa-879b-c474409c4a24.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d28e6485-3489-4894-830e-0ab0b1de1de4.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0d4323b1-65e5-4c0b-9618-3885ac67ad24.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/506414/73757506414.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2022-06-05 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da18ed16-88b0-4526-9427-52389fb047b1.pdf) |
| 2022-02-22 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e5e419e-6095-47a2-a06e-bf49cfe9a712.pdf) |
| 2021-11-24 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1700837c-87dd-4659-90b0-f91382bf6b12.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2022-06-02 | [Audio Recording Of Earnings Conference Call Held On June 1, 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=480fdffd-6253-40d7-84ac-b116b4a0d486.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:31:31.315Z.